Published online before print January 22, 2002, doi: 10.1161/hc0802.104326
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:987.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Perfusion Versus Function: The Ischemic Cascade in Demand Ischemia
Implications of Single-Vessel Versus Multivessel Stenosis
From the Cardiac Imaging Center, Cardiovascular Division, University of Virginia School of Medicine, Charlottesville, Va.
Correspondence to Sanjiv Kaul, MD, Box 158, Cardiovascular Division, University of Virginia Health Sciences Center, Charlottesville, VA 22908. E-mail sk{at}virginia.edu
Background— We hypothesized that during demand ischemia, abnormal perfusion will precede abnormal function, the spatial extent of perfusion abnormality will be greater than that of functional abnormality, and the spatiotemporal disparity between abnormal perfusion and abnormal function will be more marked in the presence of single-vessel stenosis (SVS) versus multivessel stenosis (MVS).
Methods and Results— Nine dogs each underwent either SVS or MVS placement. These noncritical stenoses were classified as mild, moderate, or severe on the basis of the transstenotic pressure gradient (10 to 14, 15 to 20, or >20 mm Hg). Dobutamine was infused starting at 10 and reaching 40 µg/kg-1 · min-1. Wall thickening (WT) and myocardial perfusion (myocardial contrast echocardiography) were assessed at each stage. Resting perfusion and function were normal in all dogs. In SVS, abnormal perfusion (delayed rate of microbubble replenishment) was seen at the lowest dose of dobutamine irrespective of the stenosis severity, whereas WT abnormality was seen only at high doses of dobutamine and was influenced by the stenosis severity. The spatial extent of abnormal perfusion exceeded that of WT abnormality at all but the highest dobutamine dose. This spatiotemporal discordance between abnormal perfusion and function was significantly less in MVS, where it was possible to identify separate regions with abnormal function at lower doses of dobutamine.
Conclusions— These data support the occurrence of the ischemic cascade during demand ischemia. They also explain the higher sensitivity of abnormal perfusion compared with abnormal function for the detection of coronary stenosis as well as the higher sensitivity of dobutamine echocardiography for MVS compared with SVS.
Key Words: perfusion • ischemia • stenosis • vessels
This article has been cited by other articles:
 |
|
 |
|
  S. Kaul Myocardial Contrast Echocardiography: A 25-Year Retrospective Circulation, July 15, 2008; 118(3): 291 - 308. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xie, S. Dodla, E. O'Leary, and T. R. Porter Detection of Subendocardial Ischemia in the Left Anterior Descending Coronary Artery Territory With Real-Time Myocardial Contrast Echocardiography During Dobutamine Stress Echocardiography J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 271 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Tsutsui, F. Xie, D. Cloutier, S. Kalvaitis, A. Elhendy, and T. R. Porter Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly Eur. Heart J., February 1, 2008; 29(3): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hoffmann, A. C. Borges, J. D. Kasprzak, S. von Bardeleben, C. Firschke, C. Greis, M. Engelhardt, H. Becher, and J. L. Vanoverschelde Analysis of myocardial perfusion or myocardial function for detection of regional myocardial abnormalities. An echocardiographic multicenter comparison study using myocardial contrast echocardiography and 2D echocardiography Eur J Echocardiogr, December 1, 2007; 8(6): 438 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Tsutsui, A. Elhendy, J. R. Anderson, F. Xie, A. C. McGrain, and T. R. Porter Prognostic Value of Dobutamine Stress Myocardial Contrast Perfusion Echocardiography Circulation, September 6, 2005; 112(10): 1444 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Leong-Poi, M. P. Coggins, J. Sklenar, A. R. Jayaweera, X.-Q. Wang, and S. Kaul Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia J. Am. Coll. Cardiol., February 15, 2005; 45(4): 565 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elhendy, E. L. O'Leary, F. Xie, A. C. McGrain, J. R. Anderson, and T. R. Porter Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Moir, B. A. Haluska, C. Jenkins, R. Fathi, and T. H. Marwick Incremental Benefit of Myocardial Contrast to Combined Dipyridamole-Exercise Stress Echocardiography for the Assessment of Coronary Artery Disease Circulation, August 31, 2004; 110(9): 1108 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lepper, T. Belcik, K. Wei, J. R. Lindner, J. Sklenar, and S. Kaul Myocardial Contrast Echocardiography Circulation, June 29, 2004; 109(25): 3132 - 3135. [Full Text] [PDF]
|
|
|
|
 |
|
 M J Monaghan Stress myocardial contrast echocardiography Heart, December 1, 2003; 89(12): 1391 - 1393. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Kraitchman, S. Sampath, E. Castillo, J. A. Derbyshire, R. C. Boston, D. A. Bluemke, B. L. Gerber, J. L. Prince, and N. F. Osman Quantitative Ischemia Detection During Cardiac Magnetic Resonance Stress Testing by Use of FastHARP Circulation, April 22, 2003; 107(15): 2025 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Bin, R. A. Pelberg, K. Wei, D. E. Le, N. C. Goodman, and S. Kaul Dobutamine versus dipyridamole for inducing reversible perfusion defects in chronic multivessel coronary artery stenosis J. Am. Coll. Cardiol., July 3, 2002; 40(1): 167 - 174. [Abstract] [Full Text] [PDF]
|
|